Literature DB >> 29120742

The Human Microbiome and Obesity: Moving beyond Associations.

Padma Maruvada1, Vanessa Leone2, Lee M Kaplan3, Eugene B Chang4.   

Abstract

Mounting evidence indicates that the gut microbiome responds to diet, antibiotics, and other external stimuli with speed and high precision and in ways that impact a variety of metabolic conditions including obesity and non-alcoholic fatty liver disease. Despite a decade of research establishing a strong association between the gut microbiota and obesity in humans, a causal relationship and the underlying mechanism remain outstanding. Several technological and methodological limitations in obesity and microbiome research have made it difficult to establish causality in this complex relationship. Additionally, limited collaborative interaction between microbiome and obesity researchers has delayed progress. Here, we discuss the current status of microbiome research as it relates to understanding obesity from the perspective of both communities, outline the underlying research challenges, and suggest directions to advance the obesity-microbiome field as a whole, with particular emphasis on the development of microbiome-targeted therapies for obesity prevention and treatment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DIO; MTT; animal models; diet-induced obesity; energy balance; energy expenditure; energy intake; microbial metabolites; microbiome; microbiota; microbiota-targeted therapies; obesity

Mesh:

Year:  2017        PMID: 29120742     DOI: 10.1016/j.chom.2017.10.005

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  126 in total

Review 1.  Ah receptor ligands and their impacts on gut resilience: structure-activity effects.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin
Journal:  Crit Rev Toxicol       Date:  2020-06-29       Impact factor: 5.635

Review 2.  What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice: Summary from a Pennington Scientific Symposium.

Authors:  Emily Qualls-Creekmore; Kara L Marlatt; Esther Aarts; Annadora Bruce-Keller; Tim S Church; Karine Clément; Jennifer O Fisher; Penny Gordon-Larsen; Christopher D Morrison; Helen E Raybould; Donna H Ryan; Philip R Schauer; Alan C Spector; Maartje S Spetter; Garret D Stuber; Hans-Rudolf Berthoud; Eric Ravussin
Journal:  Obesity (Silver Spring)       Date:  2020-06-10       Impact factor: 5.002

Review 3.  Microbiome diurnal rhythmicity and its impact on host physiology and disease risk.

Authors:  Samuel Philip Nobs; Timur Tuganbaev; Eran Elinav
Journal:  EMBO Rep       Date:  2019-03-15       Impact factor: 8.807

4.  Maternal high-fat diet results in microbiota-dependent expansion of ILC3s in mice offspring.

Authors:  Sarah Thomas Babu; Xinying Niu; Megan Raetz; Rashmin C Savani; Lora V Hooper; Julie Mirpuri
Journal:  JCI Insight       Date:  2018-10-04

Review 5.  Influence of Early Life, Diet, and the Environment on the Microbiome.

Authors:  Tien S Dong; Arpana Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-07       Impact factor: 11.382

Review 6.  Tools for Analysis of the Microbiome.

Authors:  Jessica Galloway-Peña; Blake Hanson
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

7.  Impact of the Human Microbiome in Forensic Sciences: a Systematic Review.

Authors:  Manuel G García; María D Pérez-Cárceles; Eduardo Osuna; Isabel Legaz
Journal:  Appl Environ Microbiol       Date:  2020-10-28       Impact factor: 4.792

8.  Autoinducer-2 of gut microbiota, a potential novel marker for human colorectal cancer, is associated with the activation of TNFSF9 signaling in macrophages.

Authors:  Qing Li; Wei Peng; Jiao Wu; Xianfei Wang; Yixing Ren; Huan Li; Yan Peng; Xiaowei Tang; Xiangsheng Fu
Journal:  Oncoimmunology       Date:  2019-06-10       Impact factor: 8.110

Review 9.  Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States.

Authors:  Cristina Aguayo-Mazzucato; Paula Diaque; Sonia Hernandez; Silvia Rosas; Aleksandar Kostic; Augusto Enrique Caballero
Journal:  Diabetes Metab Res Rev       Date:  2018-12-04       Impact factor: 4.876

10.  Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.

Authors:  Tien S Dong; Hui-Hua Chang; Meg Hauer; Venu Lagishetty; William Katzka; Enrique Rozengurt; Jonathan P Jacobs; Guido Eibl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.